bene-Arzneimittel GmbH is a medium-sized pharmaceutical company with a strong focus on analgesic, pediatric, and urological medicines. With over 70 years of experience in the industry, the company has established itself as a pioneer in the production of high-quality medicinal products. Notably, bene has been at the forefront of paracetamol innovation in Germany, demonstrating a profound expertise in treating children and other sensitive patient groups. Furthermore, the company is renowned for its development of unique and innovative pharmaceuticals, such as those containing the active ingredient pentosan polysulphate. Currently, bene-Arzneimittel GmbH is involved in the development, production, and sale of a diverse range of medicinal products and medical devices, catering to the German market as well as selected countries globally. The company's unyielding commitment to product quality and innovation, paired with its extensive industry experience, positions it as a noteworthy player in the Health Care and Pharmaceutical sectors.
There is no investment information
No recent news or press coverage available for bene-Arzneimittel GmbH.